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9Using our new method of purposeful modifi cation of natural molecules 
by alkylation, it is possible to enhance 
the resistance of living organisms to 
unfavourable environmental factors, 
to prevent mass viral and bacterial 
diseases, including the tumour growth, 
immunoagressive and immune defi ciency 
conditions. A possible regulatory effect 
of such substances upon the inherited 
disorders and radioactive poisoning is to 
be especially noted. 
The approach for obtaining a large 
group of antitumor products from 
alkylation of isoquinoline alkaloids of 
triethyphoms, elaborated in collaboration 
with M. Turkevich, M. Oliyovskaya and 
V. Ya. Novitsky in 1969, was patented in 
16 countries. 
Altogether there were over 
60 preparations registered as biologically 
active substances of this new type in 
the public register of the former USSR. 
They were created by the author in 
collaboration with the team of scientists 
in Lviv and Kyiv, and protected by 
40 author's certifi cates, 5 patents of 
Ukraine and 14 international patents.
The fi rst substance of this type, 
together with its analogues able to stop 
the destructive actions, was anti-tumour, 
antiviral and antimicrobial, immune-
regulating preparation amitozyn, which 
was devised in 1959 through alkylation 
of the sum of alkaloids, extracted from 
a well-known plant – greater celandine 
(Chelidonium majus L.), by anti-
tumour preparation thiophosphoamide 
(ThioTEPA) (A. I. Potopalsky, 1961) 
[1-4]. Here is the scheme 1 of the 
amitozyn synthesis.
For over fi fty years this preparation 
has been used independently and in 
many complexes for malignant and 
benign tumours, immune aggressive and 
viral formed treatment. The clinical test 
of amitozyn, conducted in 1967-1968 
in the former USSR, proved its high 
medicinal properties in the treatment of 
tumours of larynx, cervix uteri, prostate, 
ovaries, pancreas and mammary gland, 
Fig. Scheme of amitozyn synthesis
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urinary bladder, melanoblastoma 
etc., as well as in treatment of non-
malignant tumours (polyps, papillomas, 
adenomas, fi bromiomas). According 
to the Ministry of Health of Ukraine, 
these data were supported by clinical 
studies of amitozyn, conducted in 
1998-2001 on the basis of the Oncology 
and Medical Radiology Research Institute 
of the Academy of Medical Sciences of 
Ukraine. In collaboration with doctor 
O.S. Abrahamovich, amitozyn was 
proved to possess high medicinal 
effectiveness in relation to viral 
infectious polyarticular rheumatoid 
arthritis. Amitozyn did not inhibit 
hemopoiesis and immunity of patients, 
but even improved them, promoting the 
resistance of an organism. It is the fi rst 
preparation of a new class of phytolytic 
substances – products of alkylation of 
amines with various actions.
The toxicity of amitozyn is 
several times lower than of some 
of its components – the sum of 
greater celandine alkaloids and 
thiophosphamide. And high anti-tumour 
activity of amitozyn in the experiment 
was proved in its clinical trials on patients 
with fatal forms of malignant tumours 
(table 1). Complete clinical recovery 
was observed in 17-18% cases, whereas 
observed contraction of tumours and 
life prolongation was observed in 75% 
cases. Complications common to most 
anti-tumour preparations (hemopoiesis 
inhibition, dyspeptic effects, hair loss and 
others) were not observed. At the same 
time characteristics of immunogram 
were normalized and specifi c cancerous 
antigens disappeared or decreased 
dramatically. In this case most of cancer 
cells died through apoptosis - the natural 
aging process. [5] Inherited resistance 
effect in rats race cured from Heren 
cancer was determined.
Recently it has been found [6] that 
amitozyn is active against malaria. 
Malaria caused by Plasmodium 
falciparum is the most virulent form of 
malaria, leading to approximately half a 
million deaths per year. Chemotherapy 
continues to be a key approach in 
malaria prevention and treatment. Due 
to widespread drug resistance of the 
parasite, identifi cation and development 
of new anti-malarial compounds 
remains an important task of malarial 
parasitology. 
The anti-malarial effects of 
amitozyn alone and in combination 
with chloroquine, pyrimethamine and 
artemisinin on the blood stages of P. 
falciparum demonstrate that amitozyn 
effectively inhibits the growth of blood-
stage parasites with IC 50 9.6 ± 2, 
11.3 ± 2.8 and 10.8 ± 1.8 μg/mL using 
CS2, 3G8 and NF54 parasite lines, 
respectively. Treatment of uninfected 
red blood cells with a high dose of 
amitozyn (500 μg/mL) did not change 
the cell morphology, demonstrating 
its non-toxicity for erythrocytes The 
synergistic impact of the amitozyn/
chloroquine combination was observed 
at growth inhibition levels of 10–80 %, 
while demonstrating a nearly additive 
effect at a growth inhibition level of 
90 %. The combination of amitozyn with 
pyrimethamine has a synergistic effect 
at growth inhibition levels of 10–70 % 
and a nearly additive effect at a growth 
inhibition level of 90 %. The synergistic 
anti-malarial effect of the amitozyn/
artemisinin combination was observed 
at growth inhibition levels of 10–40 % 
and a nearly additive effect at growth 
inhibition levels of 50–90 %. 
Another unique preparation - 
"Izatizon", which is ratifi ed and 
successfully used for prevention and 
treatment of viral and bacterial-viral 
infections and tumours in veterinary 
medicine, medicine, crop production (and 
also - as an effective immune modulator) 
was developed in collaboration with 
L.V. Lozyuk in the year of 1973 [7, 8] 
L.A. Zaika and O.I. Bolsunova 
discovered and interpreted the 
immunomodulatory properties of 
izatizon. In close cooperation with 
D.M. Hovorun, in particular it was 
found out that a wide range of izatizon 
biological activities is based on the 
conformationally-labile structure of the 
molecule of metysazon - the main active 
component of the drug, and depends on 
the properties of the solvent and micro 
environment [9, 10].
Izatizon is a new generation drug 
that combines the antiviral activity and 
immunotropic action, and in addition 
has anticancer properties, especially 
in relation to melanoblastoma. It 
has been experimentally proved that 
izatiaon affects both viruses and cellular 
mechanisms of the immune system. 
In model systems of herpes virus and 
adenovirus we detected that izatizon has 
the ability to stimulate the activity of 
reparative DNA synthesis. [11]
We discovered the ability of the drug 
to inhibit the thymidine kinase activity of 
the herpes virus and the adenovirus, which 
leads to the inhibition of the virus in the 
early stages of infection. We discovered 
the curative effect of izatizon under the 
herpes virus infection and adenoviral 
infection, and its availability at AIDS, 
tuberculosis and viral hepatitis C. Our 
data shows the convincing signifi cance 
of this drug, especially nowadays, when 
all the continents of the Earth face the 
dramatic increase of the number of viral 
and immune aggressive diseases, that 
were considered to have disappeared, as 
well as emergence of new ones, among 
which the virus diseases occupy an 
important place. Izatizon is active against 
DNA-and RNA-containing viruses. It 
also has pronounced immunomodulatory 
properties [12].
Izatizon is an activator of nonspecifi c 
resistance factors through its stimulating 
effect on the expression of metabolic and 
phagocytic function of macrophages, 
and its infl uence on natural killer cells 
activity and synthesis of lysozyme.
Altogether there are over 60 new 
preparations with anti-tumour, antiviral 
and immune modulating action patented; 
15 original phyto teas are elaborated 
on the basis of celandine; over 20 new 
forms, varieties and types of medical 
and agricultural plants are created, 6 
of which are approved by the State 
Table 1. 
Overall result of amitozyn treatment of patients with head and neck malignant 
tumors (survival, %).
Survival Patients group
Control group Main group
2-year 52,2 ± 4,2 91,9±3,5*
3-year 47,0 ± 5,0 70,1±5,0*
5-year 40,2 ± 5,2 66,1±6,6*
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Inspection of Plant Varieties of Ukraine 
and recommended for wide use as new 
varieties with high yield and high content 
of active substances. Eleven from the 
indicated phyto teas with celandine and 
dozens of other plants are produced by 
Zhitomir closed company "Medherbs" 
under the brand of "Doctor А.I. Poto-
palsky" (Certifi cate on a trademark No. 
109425): Angiotumorosan, Artrourosan, 
Ghastrosan, Dermosan, Enterosan, 
Imunosan, Pneumosan, Tumorosan, 
Urosan, Kholeurosan, Cardiosan. They 
recover an organism, treat benign 
and malignant tumours, polyarthritis, 
multiple sclerosis. Plants of own 
selection: Purple Echinacea of "Beauty 
of Polissya", "Blueness of Polissya" 
viper's bugloss, molecular hybrid of 
pumpkin and watermelon "Zdorovyaga" 
kavbuz - are used for production of 
such recommended food supplements 
as "Spokiy" (Calmness), "Badioryst’" 
(Vivacity), "Bud’mo zdorovi" (Be 
healthy), "Kavbuzol", "Kavbuzosorb", 
kavbusorb anthelmintic, kavbusorb 
rejuvenating.
A number of the newest 
biotechnologies were elaborated: 
targeted improvement of genetic 
information of biological objects; 
environmental cleansing by application 
of plants able to assimilate atmospheric 
nitrogen instead of expensive fertilizers; 
obtaining of good crop capacity of 
plants on highly saline soils; increase of 
productivity of benefi cial insects, fi shes, 
birds, animals; a method to control 
agrobacterial cancer of plants.[13] In 
1979 on the territory of 40 hectares of the 
non-cropland in the village of Khodaky 
of Korostensky district in Zhytomyr 
region, the arboretum "Peremoga" was 
laid with the goal to establish a selective 
seed base and as the improving rest area. 
Based on nucleic acids and their 
components, some preparations - 
stimulants of plant growth - are being 
currently developed. Methods of native 
and modifi ed nucleic acids application 
for modifi cation of the genetic apparatus 
of plants are under development. [14].
Genetic effects of alkylated DNA are 
identifi ed and some new varieties and 
forms of rye, millet and tomatoes with 
valuable qualities have been obtained. A 
special sort of fodder lupine with extra 
protein "Industrial", pumpkin Kavbuz 
"Zdorovyaha", rye "Drevlyanske", 
tomato "Ukrainian", and Echinacea 
"Woodland Beauty" are registered in 
the State Register of Ukraine; plants are 
protected by the copyright certifi cates of 
Ukraine. A pilot study of alkaloids of the 
modifi ed products and their analogues 
and derivatives with a wide range of 
biological activity is carried out. These 
results are used to improve human health 
and the environment.
A technology aimed at obtaining 
the new forms of plants with the desired 
economic properties is created using 
the approach of structural modifi cation 
of molecules-carriers of hereditary 
information (DNA and RNA). 
Wide application of these 
achievements has a considerable 
economic and social effect, in particular, 
for environmental recovery, obtaining 
heavy yields on highly saline and 
nitrogen-depleted soils, and also during 
the hydroponic growing with the use 
of seawater without its desaltation. 
The created hybrids impress even 
professional selectionists: kvagista 
(molecular hybrid of haricot and 
cabbage) is an unique edible and feed 
culture that is up to three meters high with 
large protein content; kavbuz (molecular 
hybrid of pumpkin and watermelon) 
is the world largest berry of more than 
60 kilos of weight promoting the removal 
of heavy metals and radionuclides from 
the organism; Kiziris (molecular hybrid of 
cornel and barberry); Alycos (molecular 
hybrid of cherry-plum and apricot). 
The high viral and immune-modelling 
effect of amitozyn and izatizon were 
proved in 1992-1994 by the program 
of the National AIDS Committee, 
established by the President of Ukraine. 
However these developments have not 
been implemented.
We offer fi nished scientifi c 
elaborations, complex methods of 
recovery of humans and environment to 
interested collectives for collaborative 
implementation:
- Having no analogues in the 
world practice antiviral, antimicrobial 
and anti-tumour preparations 
"Izatizon", "Izatitoniy", "Amitozyn", 
“Amitozynoberamid” with high 
economic effect when using in medicinal 
care, veterinary medicine and crop 
production;
- New varieties of cereals with 
high productivity on nitrogen-depleted 
and highly saline soils (wheat, rye, 
oat, millet, barley, corn, sorghum, 
rice), resistant to drought, bacterial and 
mycotic infections;
- New types of pumpkin for 
introduction to farming (kavbuz, 
kavbudek, enriched in sugars, fructose in 
particular, carotene and oil);
- New varieties and forms of 
medicinal plants, which have the 
immunomodulating, bactericidal and 
anti-infl ammatory effects (Echinacea, 
viper's bugloss, elecampane, thermopsis, 
phytolacca);
- Salt-resistant and drought-
resistant forms of plants, tomatoes of 
the "Ukrainian Salt Tolerant" variety in 
particular;
- Technologies of processing of 
seeds of cereals and vegetable cultures, 
and treatment of mushrooms, which 
increase the productivity by 20-40%;
- Technology of benefi cial insects’ 
productivity improvement in beekeeping, 
production of oakworm and silkworm, etc.; 
proposed biopreparations are not harmful 
and provide the growth of productivity of 
benefi cial insects by 1.5-2 times;
- Technology of creation of new 
forms of plants with modifi ed properties 
(creation of frost-resistant, salt-resistant, 
drought-resisting forms, transformation 
of winter forms of crops into the spring 
crops);
- Technology of fi shery and sea-
farming productivity improvement by 
20-40%;
- Technology of diagnostics, 
prevention and treatment of bacterial 
cancer of plants (fruit cultures, grapes, 
vegetable cultures) by using original, 
ecologically harmless preparations.
In 2005 the International scientifi c-
practical forum "Bases of molecular-
genetic health improvement of both 
human and environment" took place 
at the Institute of Molecular Biology 
and Genetics. It was dedicated to a new 
scientifi c direction of modifi cation of the 
molecular structure of biologically active 
substances, which were extremely highly 
appreciated at home and abroad. Materials 
of this forum are presented on the web-site 
http://www.potopalsky.kiev.ua/ua/forum.
html. Number of visitors from more than 
50 countries is still growing.
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